WallStreetZenWallStreetZen

NASDAQ: MGNX
Macrogenics Inc Stock Ownership - Who owns Macrogenics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Macrogenics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Thomas SpitznagelSr VP Technical Ops2025-02-155,520$2.56
$14.13kSell
Stephen L. EckChief Medical Officer2025-02-154,942$2.56
$12.65kSell
James KarrelsSVP CFO and Secretary2025-02-155,790$2.56
$14.82kSell
Jeffrey Stuart PetersSenior VP and General Counsel2025-02-155,147$2.56
$13.18kSell
Eric Blasius RisserChief Operating Officer2025-02-156,433$2.56
$16.47kSell
Beth Ann SmithVP Controller Treasurer2025-02-15423$2.56
$1.08kSell
Ezio BonviniSr VP Research CSO2025-02-084,311$2.60
$11.21kSell
Eric Blasius RisserChief Operating Officer2025-02-084,311$2.60
$11.21kSell
Stephen L. EckChief Medical Officer2025-02-083,312$2.60
$8.61kSell
Thomas SpitznagelSr VP Technical Ops2025-02-083,727$2.60
$9.69kSell

1 of 2

MGNX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MGNX insiders and whales buy or sell their stock.

MGNX Shareholders

What type of owners hold Macrogenics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Target N. V. Biotech15.74%9,929,963$16.48MInsider
Vanguard Group Inc6.68%4,213,114$6.99MInstitution
Acadian Asset Management LLC3.95%2,491,703$4.14MInstitution
Tpg Group Holdings Sbs Advisors Inc3.50%2,208,762$3.67MInsider
Scott Koenig3.29%2,076,090$3.45MInsider
Alta Biopharma Partners III LP3.19%2,013,509$3.34MInsider
Interwest Partners VIII LP3.03%1,908,716$3.17MInsider
Blackrock Inc2.88%1,817,529$3.02MInstitution
Edward Hurwitz2.77%1,749,070$2.90MInsider
Arnold L. Oronsky2.71%1,708,716$2.84MInsider

1 of 3

MGNX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MGNX22.63%37.58%Net Selling
TCRX21.84%29.87%Net BuyingNet Buying
SKYE0.68%99.32%Net Selling
ATOS9.80%11.04%Net BuyingNet Buying
BMEA13.48%28.91%Net Buying
View Top Biotech Stocks

Macrogenics Stock Ownership FAQ

Who owns Macrogenics?

Macrogenics (NASDAQ: MGNX) is owned by 22.63% institutional shareholders, 37.58% Macrogenics insiders, and 39.79% retail investors. Target N. V. Biotech is the largest individual Macrogenics shareholder, owning 9.93M shares representing 15.71% of the company. Target N. V. Biotech's Macrogenics shares are currently valued at $16.09M.

If you're new to stock investing, here's how to buy Macrogenics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.